Published in Infect Immun on November 01, 1999
TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat Immunol (2010) 4.56
An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells. Infect Immun (2003) 4.37
Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat Rev Immunol (2010) 3.56
Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2. J Exp Med (2000) 3.20
Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proc Natl Acad Sci U S A (2003) 3.18
Francisella tularensis: taxonomy, genetics, and Immunopathogenesis of a potential agent of biowarfare. Annu Rev Microbiol (2006) 2.68
Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells. Infect Immun (2000) 2.53
Splenic T zone development is B cell dependent. J Exp Med (2001) 2.35
A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. J Immunol (2005) 2.26
In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70. Infect Immun (2002) 2.02
Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity. Infect Immun (2001) 1.91
How B cells shape the immune response against Mycobacterium tuberculosis. Eur J Immunol (2009) 1.61
Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells. Infect Immun (2001) 1.61
Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production. J Exp Med (2000) 1.55
Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis. Immunol Rev (2008) 1.48
CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo. J Exp Med (2005) 1.44
Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon. Infect Immun (2000) 1.42
Immunity to Francisella. Front Microbiol (2011) 1.37
Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia. Infect Immun (2006) 1.27
IgM in microbial infections: taken for granted? Immunol Lett (2009) 1.23
Levofloxacin rescues mice from lethal intra-nasal infections with virulent Francisella tularensis and induces immunity and production of protective antibody. Vaccine (2008) 1.19
Cytotoxic T cells are the predominant players providing cross-protective immunity induced by {gamma}-irradiated influenza A viruses. J Virol (2010) 1.12
Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cells. Infect Immun (2005) 1.11
The role of B cells and humoral immunity in Mycobacterium tuberculosis infection. Adv Exp Med Biol (2013) 1.09
Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia. PLoS One (2012) 1.04
Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strains. Infect Immun (2011) 1.00
The role of B cells and humoral immunity in Mycobacterium tuberculosis infection. Semin Immunol (2014) 0.98
Effective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigens. PLoS Pathog (2010) 0.97
B cell depletion curtails CD4+ T cell memory and reduces protection against disseminating virus infection. J Immunol (2014) 0.93
IL-12Rβ2 is critical for survival of primary Francisella tularensis LVS infection. J Leukoc Biol (2013) 0.91
Characterization of monoclonal antibodies to terminal and internal O-antigen epitopes of Francisella tularensis lipopolysaccharide. Hybridoma (Larchmt) (2011) 0.90
Unraveling effector functions of B cells during infection: the hidden world beyond antibody production. Infect Disord Drug Targets (2012) 0.89
Identification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets. Immunology (2011) 0.88
Mucosal immunization with live attenuated Francisella novicida U112ΔiglB protects against pulmonary F. tularensis SCHU S4 in the Fischer 344 rat model. PLoS One (2012) 0.87
Protective B-cell epitopes of Francisella tularensis O-polysaccharide in a mouse model of respiratory tularaemia. Immunology (2012) 0.84
Immunotherapy for tularemia. Virulence (2013) 0.81
IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infection. Vaccine (2014) 0.80
Francisella tularensis Vaccines Elicit Concurrent Protective T- and B-Cell Immune Responses in BALB/cByJ Mice. PLoS One (2015) 0.80
Phenotypic, morphological, and functional heterogeneity of splenic immature myeloid cells in the host response to tularemia. Infect Immun (2012) 0.78
Antibodies to both terminal and internal B-cell epitopes of Francisella tularensis O-polysaccharide produced by patients with tularemia. Clin Vaccine Immunol (2013) 0.77
Activities of Murine Peripheral Blood Lymphocytes Provide Immune Correlates That Predict Francisella tularensis Vaccine Efficacy. Infect Immun (2016) 0.76
Antigen presentation by B cells guides programing of memory CD4(+) T-cell responses to a TLR4-agonist containing vaccine in mice. Eur J Immunol (2016) 0.75
Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis? Front Immunol (2017) 0.75
B-cell epitopes in GroEL of Francisella tularensis. PLoS One (2014) 0.75
A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature (1991) 13.19
Nature of protective immunity to Francisella tularensis. Rev Infect Dis (1989) 4.75
Live vaccine strain of Francisella tularensis: infection and immunity in mice. Infect Immun (1991) 3.99
In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies. Infect Immun (1992) 3.07
Listeria monocytogenes infection in nude mice. Infect Immun (1975) 2.82
Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J Exp Med (1997) 2.67
Successful T cell priming in B cell-deficient mice. J Exp Med (1995) 2.52
Minimal requirements for murine resistance to infection with Francisella tularensis LVS. Infect Immun (1996) 2.50
B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J Immunol (1995) 2.29
Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth. J Clin Microbiol (1985) 2.26
Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect Immun (1997) 2.26
Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice. J Immunol (1996) 2.21
Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J Virol (1995) 2.06
Theta-bearing lymphocytes in nude mice. Nature (1973) 2.06
Mechanism of protective immunity against influenza virus infection in mice without antibodies. J Immunol (1998) 2.03
The binary logic of antigen processing and presentation to T cells. Cell (1990) 2.03
CD8 T cell memory in B cell-deficient mice. J Exp Med (1996) 1.97
The B/macrophage cell: an elusive link between CD5+ B lymphocytes and macrophages. Immunol Today (1996) 1.94
Control of early Salmonella typhimurium growth in innately Salmonella-resistant mice does not require functional T lymphocytes. J Immunol (1982) 1.90
Clearance of an influenza A virus by CD4+ T cells is inefficient in the absence of B cells. J Virol (1998) 1.87
Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes. J Exp Med (1997) 1.81
Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells. Infect Immun (1994) 1.75
A role for B cells in the development of T cell helper function in a malaria infection in mice. Proc Natl Acad Sci U S A (1998) 1.73
Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J Immunol (1996) 1.73
T-cell-independent resistance to infection and generation of immunity to Francisella tularensis. Infect Immun (1993) 1.62
Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection. J Immunol (1998) 1.56
Introduction of Francisella tularensis at skin sites induces resistance to infection and generation of protective immunity. Microb Pathog (1992) 1.56
CD4+ T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling. J Exp Med (1998) 1.56
Long-lasting CD8 T cell memory in the absence of CD4 T cells or B cells. J Exp Med (1996) 1.50
Increase of tuberculous infection in the organs of B cell-deficient mice. Clin Exp Immunol (1996) 1.36
Gene-targeted B-deficient mice reveal a critical role for B cells in the CD4 T cell response. Int Immunol (1995) 1.35
B-1 cells: unique origins and functions. Semin Immunol (1996) 1.33
Peptide and protein antigens require distinct antigen-presenting cell subsets for the priming of CD4+ T cells. J Immunol (1995) 1.32
Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J Infect Dis (1995) 1.26
Mycobacterium tuberculosis aerogenic rechallenge infections in B cell-deficient mice. Tuber Lung Dis (1997) 1.24
Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms. J Immunol (1999) 1.24
Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man. Immunology (1992) 1.18
A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J Immunol (1997) 1.16
Antigen-primed T cells from B cell-deficient JHD mice fail to provide B cell help. J Immunol (1998) 1.14
Rapid generation of specific protective immunity to Francisella tularensis. Infect Immun (1992) 1.12
B cell activation, tolerance and antigen-presenting function. Curr Opin Immunol (1995) 1.12
Immune effector mechanisms required for protection to rabies virus. Virology (1995) 0.98
Trafficking of adoptively transferred B lymphocytes in B-lymphocyte-deficient mice. J Exp Biol (1997) 0.98
Nonspecific early protective immunity in Francisella and Listeria infections can be dependent on lymphocytes. Infect Immun (1998) 0.94
A dual role for B cells in Plasmodium chabaudi chabaudi (AS) infection? Res Immunol (1995) 0.87
Interactions between B lymphocytes and NK cells. FASEB J (1994) 0.83
Minimal requirements for murine resistance to infection with Francisella tularensis LVS. Infect Immun (1996) 2.50
Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J Immunol (1999) 2.23
Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J Immunol (1996) 1.73
Ebola virus: the search for vaccines and treatments. Cell Mol Life Sci (2001) 1.18
Nonspecific early protective immunity in Francisella and Listeria infections can be dependent on lymphocytes. Infect Immun (1998) 0.94